These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 27560280

  • 1. Synthesis, binding assays, cytotoxic activity and docking studies of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
    Romero-Parra J, Mella-Raipán J, Palmieri V, Allarà M, Torres MJ, Pessoa-Mahana H, Iturriaga-Vásquez P, Escobar R, Faúndez M, Di Marzo V, Pessoa-Mahana CD.
    Eur J Med Chem; 2016 Nov 29; 124():17-35. PubMed ID: 27560280
    [Abstract] [Full Text] [Related]

  • 2. Combined CoMFA and CoMSIA 3D-QSAR study of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
    Romero-Parra J, Chung H, Tapia RA, Faúndez M, Morales-Verdejo C, Lorca M, Lagos CF, Di Marzo V, David Pessoa-Mahana C, Mella J.
    Eur J Pharm Sci; 2017 Apr 01; 101():1-10. PubMed ID: 28137469
    [Abstract] [Full Text] [Related]

  • 3. Benzimidazoles as new scaffold of sirtuin inhibitors: green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties.
    Yoon YK, Ali MA, Wei AC, Shirazi AN, Parang K, Choon TS.
    Eur J Med Chem; 2014 Aug 18; 83():448-54. PubMed ID: 24992072
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, biological evaluation and binding mode modeling of benzimidazole derivatives targeting the cannabinoid receptor type 1.
    Espinosa-Bustos C, Lagos CF, Romero-Parra J, Zárate AM, Mella-Raipán J, Pessoa-Mahana H, Recabarren-Gajardo G, Iturriaga-Vásquez P, Tapia RA, Pessoa-Mahana CD.
    Arch Pharm (Weinheim); 2015 Feb 18; 348(2):81-8. PubMed ID: 25641513
    [Abstract] [Full Text] [Related]

  • 5. Novel benzimidazole derivatives as selective CB2 agonists.
    Pagé D, Balaux E, Boisvert L, Liu Z, Milburn C, Tremblay M, Wei Z, Woo S, Luo X, Cheng YX, Yang H, Srivastava S, Zhou F, Brown W, Tomaszewski M, Walpole C, Hodzic L, St-Onge S, Godbout C, Salois D, Payza K.
    Bioorg Med Chem Lett; 2008 Jul 01; 18(13):3695-700. PubMed ID: 18522867
    [Abstract] [Full Text] [Related]

  • 6. Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionality.
    Osman NA, Ligresti A, Klein CD, Allarà M, Rabbito A, Di Marzo V, Abouzid KA, Abadi AH.
    Eur J Med Chem; 2016 Oct 21; 122():619-634. PubMed ID: 27448919
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. 5-Sulfonyl-benzimidazoles as selective CB2 agonists.
    Verbist BM, De Cleyn MA, Surkyn M, Fraiponts E, Aerssens J, Nijsen MJ, Gijsen HJ.
    Bioorg Med Chem Lett; 2008 Apr 15; 18(8):2574-9. PubMed ID: 18394887
    [Abstract] [Full Text] [Related]

  • 12. Benzimidazole CB2 agonists: design, synthesis and SAR.
    Nanda KK, Henze DA, Della Penna K, Desai R, Leitl M, Lemaire W, White RB, Yeh S, Brouillette JN, Hartman GD, Bilodeau MT, Trotter BW.
    Bioorg Med Chem Lett; 2014 Feb 15; 24(4):1218-21. PubMed ID: 24461289
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors.
    Akhtar MJ, Siddiqui AA, Khan AA, Ali Z, Dewangan RP, Pasha S, Yar MS.
    Eur J Med Chem; 2017 Jan 27; 126():853-869. PubMed ID: 27987485
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and biological evaluation of bivalent cannabinoid receptor ligands based on hCB₂R selective benzimidazoles reveal unexpected intrinsic properties.
    Nimczick M, Pemp D, Darras FH, Chen X, Heilmann J, Decker M.
    Bioorg Med Chem; 2014 Aug 01; 22(15):3938-46. PubMed ID: 24984935
    [Abstract] [Full Text] [Related]

  • 15. Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.
    Cindrić M, Jambon S, Harej A, Depauw S, David-Cordonnier MH, Kraljević Pavelić S, Karminski-Zamola G, Hranjec M.
    Eur J Med Chem; 2017 Aug 18; 136():468-479. PubMed ID: 28525845
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis, antitumor activity and SAR study of novel [1,2,4]triazino[4,5-a]benzimidazole derivatives.
    El-Nassan HB.
    Eur J Med Chem; 2012 Jul 18; 53():22-7. PubMed ID: 22542105
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.